Caution, This content is for veterinary professionals.

Canigen® Parvo-C

Part of a flexible and convenient vaccine range

Canigen® Parvo-C is an individual component containing canine parvovirus Type 2 (CPV-2)

Product Features & Benefits: 

  • Modified live vaccine 

  • Protection from 1 week after vaccination

  • At least 3 years duration of immunity

  • Vaccination can start from 4 weeks

  • Strain C154 protects against

  • Types 2, 2b and 2c1


Presentations Available: 

Available in 10 doses. 


Available UK logo.jpg

Use medicines responsibly.
Further information is available on the SPC or on request from Virbac Ltd.